Philadelphia
,
USA
28 July - 1 August 2024
Alzheimer's Association International Conference® (AAIC 2024)
Presentation schedule and materials
The congress symposium is no longer available
Sunday, 28 July 2024
POSTER
Real-world analysis of the clinical care pathway of patients living with Alzheimer’s disease in the United States according to stage of cognitive impairment at diagnosis
Elnara Fazio-Eynullayeva1; Paul Mystkowski1; Sarah Cotton2; Eddie Jones2; Sophie Kirkman2; Lei Lv1; Soeren Mattke3
MATERIALS AVAILABLE
POSTER
Characterising subpopulations of patients with Alzheimer’s disease dementia who have high healthcare utilisation and costs
Sophie Edwards1; Dominic Trepel2; Craig Ritchie3,4; Julie Hviid Hahn-Pedersen5; Mei Sum Chan6; Benjamin D Bray6; Alice Clark5; Christian Ahmad Wichmann5; Marc Evans7
MATERIALS AVAILABLE
Monday, 29 July 2024
POSTER
Comparison of eligibility criteria and baseline characteristics between the patient populations of evoke and evoke+, Clarity AD, and TRAILBLAZER-ALZ 2
Howard H. Feldman1; Philip Scheltens2; Oskar Hansson3,4; Mary Sano5,6; Wiesje M. van der Flier7,8; Lars Bardtrum9; Peter Johannsen9; Rose Jeppesen9; Teresa León9; Charlotte T. Hansen9; Jeffrey Cummings10
MATERIALS AVAILABLE
Tuesday, 30 July 2024
POSTER
Investigating the effects of semaglutide in early Alzheimer’s disease using single-cell transcriptomics and proteomics – study rationale and design
Peter Johannsen1; Marie Bentsen1; Kate Attfield2; Kristian Steen Frederiksen3,4; Giovanni B. Frisoni5; Rose Jeppesen1; Ibrahim J. Malik1; Lotte Bjerre Knudsen1
MATERIALS AVAILABLE
POSTER
Reasons for screening failure in the evoke and evoke+ trials of semaglutide for early Alzheimer’s disease
Mary Sano1,2; Jeffrey Cummings3; Howard H. Feldman4; Oskar Hansson5,6; Wiesje M. van der Flier7,8; Lars Bardtrum9; Rose Jeppesen9; Peter Johannsen9; Teresa León9; Charlotte T. Hansen9; Philip Scheltens10
MATERIALS AVAILABLE
POSTER
Extension and External Validation of the Mapping between the Mini-Mental State Examination and the Clinical Dementia Rating scale in Patients with Alzheimer’s Disease
Niels Juul Brogaard1; Julie Hviid Hahn-Pedersen1; Jens Gundgaard1; Pepa Polavieja1; Benjamin D Bray2; Mei Sum Chan2; Men Hoang3; Daniel Araya3; Dominic Trepel3
MATERIALS AVAILABLE
Wednesday, 31 July 2024
POSTER
How to handle use of additional medication for Alzheimer’s disease during randomized clinical trials?
Claus Dethlefsen1,2; Mette Dahl Bendtsen1; Peter Johannsen3; Pepa Polavieja1
ORAL PRESENTATION
Regional differences in baseline demographic and clinical characteristics from the evoke and evoke+ trials of semaglutide for early Alzheimer’s disease
Wiesje M. van der Flier1; Philip Scheltens2; Howard H. Feldman3; Oskar Hansson4,5; Mary Sano6,7; Lars Bardtrum8; Peter Johannsen8; Rose Jeppesen8; Charlotte Thim Hansen8; Teresa León Colombo8; Jeffrey Cummings9
MATERIALS AVAILABLE
Keywords